Auto-generated event page

Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea

Tokyo, Japan and Cambridge, UK, 4 March 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that it has submitted a marketing authorisation application ...

Score 41 low confidence 1 source posts Updated Mar 4, 2026, 9:00 AM UTC

Track This Event Open Event in App More Signal Pages

Cluster sources

Newest source rows first.

Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea

GlobeNewswire Public Companies • Mar 4, 2026, 8:54 AM UTC

Entity focus

Direct link to post

https://pushme.site/signals/188053-nxera-pharma-submits-marketing-authorization-application-for-daridorexan?utm_source=signal-188053&utm_medium=social&utm_campaign=signal-pages&utm_content=hero

Quick distribution loop

Step 1

Post this live link in threads where users ask how to monitor this event.

Step 2

Point readers to "Track This Event" for immediate conversion into an alert.

Step 3

Reuse entity keywords from this page for targeted follow-up replies.

Back to signal pages Open query hub